Published in Drug Law Weekly, January 16th, 2007
The number of injuries and deaths world-wide related to counterfeit drugs is growing. While the extent of pharmaceutical counterfeiting varies among different regions in the world, there is consensus among regulatory bodies that the problem is a dangerous threat to the safety of consumers.
To address this issue, ASD’s RxSpec 700Z system enables real-time drug verification that will hopefully eradicate the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.